| Primary |
| Hypertension |
34.2% |
| Product Used For Unknown Indication |
25.6% |
| Cardiac Failure |
9.0% |
| Type 2 Diabetes Mellitus |
6.0% |
| Renal Failure |
2.8% |
| Pain |
2.2% |
| Cardiac Failure Chronic |
1.9% |
| Chronic Obstructive Pulmonary Disease |
1.9% |
| Atrial Fibrillation |
1.7% |
| Obstructive Airways Disorder |
1.7% |
| Rheumatoid Arthritis |
1.7% |
| Coronary Artery Disease |
1.5% |
| Hyperlipidaemia |
1.5% |
| Hiv Infection |
1.3% |
| Hyperuricaemia |
1.3% |
| Hypothyroidism |
1.3% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.3% |
| Diabetes Mellitus |
1.1% |
| Prophylaxis |
1.1% |
| Depression |
0.9% |
|
| Renal Failure Acute |
16.8% |
| Hypoglycaemia |
8.9% |
| Angioedema |
7.9% |
| Vomiting |
7.9% |
| Renal Failure |
5.9% |
| Swollen Tongue |
5.9% |
| Haemangioma |
4.0% |
| Hyperkalaemia |
4.0% |
| Hypotension |
4.0% |
| Renal Impairment |
4.0% |
| Respiratory Failure |
4.0% |
| Death |
3.0% |
| Dementia |
3.0% |
| Lip Swelling |
3.0% |
| Non-hodgkin's Lymphoma |
3.0% |
| Supernumerary Nipple |
3.0% |
| Swelling Face |
3.0% |
| Syncope |
3.0% |
| Urinary Tract Infection |
3.0% |
| Ventricular Tachycardia |
3.0% |
|
| Secondary |
| Product Used For Unknown Indication |
43.2% |
| Hypertension |
18.4% |
| Cardiac Failure |
7.5% |
| Drug Use For Unknown Indication |
4.8% |
| Depression |
3.7% |
| Cardiac Failure Chronic |
3.5% |
| Diabetes Mellitus |
2.7% |
| Completed Suicide |
1.9% |
| Type 2 Diabetes Mellitus |
1.7% |
| Myocardial Ischaemia |
1.6% |
| Pain |
1.6% |
| Prophylaxis |
1.4% |
| Breast Cancer |
1.2% |
| Atrial Fibrillation |
1.2% |
| Hypercholesterolaemia |
1.0% |
| Blood Pressure |
0.9% |
| Chronic Lymphocytic Leukaemia |
0.9% |
| Suicide Attempt |
0.9% |
| Thrombosis Prophylaxis |
0.9% |
| Nephrotic Syndrome |
0.9% |
|
| Renal Failure Acute |
22.8% |
| Vomiting |
12.0% |
| Hyponatraemia |
7.1% |
| Syncope |
7.1% |
| Completed Suicide |
6.0% |
| Hyperkalaemia |
4.3% |
| Respiratory Failure |
4.3% |
| Urinary Tract Infection |
4.3% |
| Death |
3.3% |
| Hypotension |
3.3% |
| Renal Impairment |
3.3% |
| Toxicity To Various Agents |
3.3% |
| Sinus Bradycardia |
2.7% |
| Somnolence |
2.7% |
| Supernumerary Nipple |
2.7% |
| Circulatory Collapse |
2.2% |
| Drug Abuse |
2.2% |
| Drug Hypersensitivity |
2.2% |
| Drug Interaction |
2.2% |
| Drug Toxicity |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.1% |
| Hypertension |
22.8% |
| Drug Use For Unknown Indication |
9.9% |
| Rheumatoid Arthritis |
6.8% |
| Diabetes Mellitus |
4.8% |
| Pain |
3.6% |
| Type 2 Diabetes Mellitus |
2.9% |
| Prophylaxis |
2.8% |
| Depression |
2.6% |
| Blood Cholesterol Increased |
2.4% |
| Atrial Fibrillation |
2.2% |
| Cardiac Disorder |
1.7% |
| Osteoporosis |
1.6% |
| Blood Pressure |
1.5% |
| Cardiac Failure |
1.3% |
| Chronic Obstructive Pulmonary Disease |
1.3% |
| Anxiety |
1.2% |
| Coronary Artery Disease |
1.2% |
| Asthma |
1.1% |
| Gastrooesophageal Reflux Disease |
1.1% |
|
| Vomiting |
15.4% |
| Weight Decreased |
9.0% |
| Weight Increased |
6.5% |
| Myocardial Infarction |
6.4% |
| Death |
5.1% |
| Pneumonia |
4.9% |
| Urinary Tract Infection |
4.9% |
| Drug Ineffective |
4.8% |
| Syncope |
4.2% |
| Thrombocytopenia |
4.1% |
| Pyrexia |
4.0% |
| Nausea |
3.9% |
| Renal Failure Acute |
3.9% |
| Pain |
3.6% |
| Pain In Extremity |
3.5% |
| Renal Failure |
3.4% |
| Tremor |
3.3% |
| Vision Blurred |
3.1% |
| Rash |
3.0% |
| Sepsis |
2.9% |
|
| Interacting |
| Hypertension |
28.1% |
| Product Used For Unknown Indication |
13.9% |
| Drug Use For Unknown Indication |
9.1% |
| Cardiac Failure |
6.5% |
| Atrial Fibrillation |
5.1% |
| Prophylaxis |
5.1% |
| Type 2 Diabetes Mellitus |
4.3% |
| Diabetes Mellitus |
4.0% |
| Renal Transplant |
2.8% |
| Renovascular Hypertension |
2.6% |
| Cardiac Failure Chronic |
2.3% |
| Cardiac Failure Congestive |
2.3% |
| Depression |
2.3% |
| Back Pain |
2.0% |
| Pain |
2.0% |
| Cardiovascular Event Prophylaxis |
1.7% |
| Pulmonary Hypertension |
1.7% |
| Blood Pressure Increased |
1.4% |
| Coronary Artery Disease |
1.4% |
| Hepatic Cirrhosis |
1.4% |
|
| Renal Failure Acute |
36.3% |
| Drug Interaction |
11.3% |
| Hyperkalaemia |
8.8% |
| Vomiting |
5.0% |
| Hypoglycaemia |
3.8% |
| Pruritus Generalised |
3.8% |
| Renal Failure Chronic |
3.8% |
| Rhabdomyolysis |
3.8% |
| Hyponatraemia |
2.5% |
| Paraesthesia |
2.5% |
| Renal Failure |
2.5% |
| Somnolence |
2.5% |
| Therapeutic Agent Toxicity |
2.5% |
| Tremor |
2.5% |
| Weight Increased |
2.5% |
| Acute Prerenal Failure |
1.3% |
| Dehydration |
1.3% |
| Gout |
1.3% |
| Hepatic Encephalopathy |
1.3% |
| Hospitalisation |
1.3% |
|
